ItchBio is developing novel treatments for chronic itching conditions with large unmet clinical needs and no approved Rx products. Our lead program, IB-242, is a repurposed API delivered topically, targeting treatment of pruritus ani, post-radiation therapy induced itch, and post-surgical itch.